Progress in virology. 5. Interferon
Presber, H.W.; Waschke, S.R.
Zeitschrift für Arztliche Fortbildung 75(6): 277-285
1981
ISSN/ISBN: 0044-2178 PMID: 6169208 Document Number: 169464
Document emailed within 1 workday
Related Documents
Przesmycki, F. 1973: Achievements of virology in Poland during the last 25 years. Virology throughout the world Postepy Higieny i Medycyny Doswiadczalnej 27(1): 1-39Shepherd, P.C.; Richards, S.M.; Allan, N.C. 1996: Progress with interferon in CML--results of the MRC UK CML IIi study Bone Marrow Transplantation 17(Suppl 3): S15-S18
Vordermeier, M.; Goodchild, A.; Clifton-Hadley, R.; de la Rua, R. 2004: The interferon-gamma field trial: background, principles and progress Veterinary Record 155(2): 37-38
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Suthar, M.; Rodrigues, C.; Soman, R.; Reed, W.; Negri, A.; Blumberg, B.Samuel.; Urbani, C. 2016: Pioneers in Virology Journal of the Association of Physicians of India 64(5): 95-96
Evtushenko, A.I. 1982: Lectins in virology Voprosy Virusologii 27(2): 132-137
Akimoto, M.; Ueki, H.; Nakajima, Y.; Matano, S.; Ewasaki, H.; Abe, R.; Kasai, M. 1984: Prevention of 5-FU induced toxicity in C3 H/HE mice with interferon or with interferon inducers (poly 1: C, OK-432, Lentinan) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(7): 1462-1467
Günther, G.; Otto, B. 1993: Interferon. An overview of the state of basic research with special regard to interferon-gamma Arzneimittel-Forschung 43(2): 182-188
Lvovsky, E.A.; D'Souza, J.; Eng, D.; D'Souza, D.; Lvovsky, B.; Hetland, R.; Craver, W.L.; Sobel, S.H. 1988: Tumor response to interferon inducer and radiation effect of serum interferon levels Journal of Biological Regulators and Homeostatic Agents 2(1): 1-6
Meager, A.; Parti, S.; Webb, K.; Exley, T. 1986: Development of interferon-specific monoclonal antibody for in vitro interferon assays Developments in Biological Standardization 64: 237-248
Sumpio, B.E.; Ernstoff, M.S.; Kirkwood, J.M. 1984: Urinary excretion of interferon, albumin, and beta 2-microglobulin during interferon treatment Cancer Research 44(8): 3599-3603
Tazulakhova, E.B.; Amitina, N.N.; Ershov, F.I. 1985: Interferon-inducing and antiviral effects of inosiplex in combination with high-molecular interferon inducers Biulleten' Eksperimental'noi Biologii i Meditsiny 100(10): 457-459
Russo, D.; Fanin, R.; Zuffa, E.; Damiani, D.; Gallizia, C.; Michieli, M.; Testoni, N.; Benfenati, D.; Visani, G.; Zaccaria, A. 1990: Sequential treatment of Ph-positive chronic myeloid leukemia with interferon gamma and interferon alpha Haematologica 75(4): 334-339
Corbillet, V.; Celerier, P.; Lebon, P.; Litoux, P.; Dreno, B. 1995: Development of interferon antibodies during the treatment of skin diseases with low-dose recombinant interferon alpha-2a Annales de Medecine Interne 146(6): 399-403
Gutman, N.R.; Manakhova, L.S. 1981: Ability of influenza virus strains to induce interferon and their sensitivity to the action of exogenous interferon Voprosy Virusologii 2: 168-171
Fleischmann, W.R.; Kleyn, K.M.; Baron, S. 1980: Potentiation of antitumor effect of virus-induced interferon by mouse immune interferon preparations Journal of the National Cancer Institute 65(5): 963-966
Rubin, B.Y.; Bartal, A.H.; Anderson, S.L.; Millet, S.K.; Hirshaut, Y.; Feit, C. 1983: The anticellular and protein-inducing activities of human gamma interferon preparations are mediated by the interferon Journal of Immunology 130(3): 1019-1020
Koyama, S.; Narita, M. 1988: In vitro effects of interferon-alpha and interferon-gamma on hematopoietic progenitor cells in bone marrow Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 51(8): 1540-1549
Weinberg, J.M.; Wolfe, J.T.; Sood, S.; Saruk, M.; Rook, A.H.; Spiers, E.M. 1997: Cutaneous necrosis associated with recombinant interferon injection. Report of three cases with interferon beta-1b and review of the literature Acta Dermato-Venereologica 77(2): 146-148
Margolick, J.B.; Ambrus, J.L.; Volkman, D.J.; Fauci, A.S. 1986: Human T4+ lymphocytes produce a phagocytosis-inducing factor (PIF) distinct from interferon-alpha and interferon-gamma Journal of Immunology 136(2): 546-554